Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker?


Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 15 5 2020
medline: 22 7 2022
entrez: 15 5 2020
Statut: ppublish

Résumé

THIS is the first time that a bronchoalveolar lavage (BAL) neutrophil-to-lymphocyte ratio (NL-ratio) has been demonstrated in sarcoidosis and chronic hypersensitivity pneumonitis (cHP) than in idiopathic pulmonary fibrosis (IPF) patients. Consecutive BAL samples from the 167 interstitial lung disease (ILD) patients were retrospectively enrolled in the study and clustered into three diagnostic categories: IPF, cHP and sarcoidosis. NL-ratio which proved higher in IPF (mean±SD, 2.1±3.8) than sarcoidosis (mean±SD 0.7±1.9; P<1E-04) and cHP patients (mean±SD 1.6±3.1; P=7.7E-03). ROC curve analysis to discriminate between Sarcoidosis and other ILDs showed an area under the curve (AUC) of 83.7%, (56% sensitivity and 96% specificity) while IPF and the other ILD were discriminated with AUC of 73% using a NL-ratio threshold value of 0.48 (73% sensitivity and 63% specificity). Interestingly, the NL-ratio was significantly correlated with other prognostic parameters: it was inversely correlated with forced vital capacity (FVC) (r=-0.3; P=2.5E-02) and forced expiration volume in 1 second (FEV1) (r=-0.3; P=2E-02) percentages and directly correlated with composite pulmonary index (CPI) score (r=0.3; P=3.2E-02). A decision-tree statistical algorithm was applied. This is the first time that a lower NL-ratio has been demonstrated in sarcoidosis and cHP than in IPF patients. The present preliminary report indicates a relationship between BAL NL-ratio and lung function parameters in patients with IPF: this ratio may help to optimize management of IPF patients and to improve follow-up and outcome.

Sections du résumé

BACKGROUND BACKGROUND
THIS is the first time that a bronchoalveolar lavage (BAL) neutrophil-to-lymphocyte ratio (NL-ratio) has been demonstrated in sarcoidosis and chronic hypersensitivity pneumonitis (cHP) than in idiopathic pulmonary fibrosis (IPF) patients.
METHODS METHODS
Consecutive BAL samples from the 167 interstitial lung disease (ILD) patients were retrospectively enrolled in the study and clustered into three diagnostic categories: IPF, cHP and sarcoidosis.
RESULTS RESULTS
NL-ratio which proved higher in IPF (mean±SD, 2.1±3.8) than sarcoidosis (mean±SD 0.7±1.9; P<1E-04) and cHP patients (mean±SD 1.6±3.1; P=7.7E-03). ROC curve analysis to discriminate between Sarcoidosis and other ILDs showed an area under the curve (AUC) of 83.7%, (56% sensitivity and 96% specificity) while IPF and the other ILD were discriminated with AUC of 73% using a NL-ratio threshold value of 0.48 (73% sensitivity and 63% specificity). Interestingly, the NL-ratio was significantly correlated with other prognostic parameters: it was inversely correlated with forced vital capacity (FVC) (r=-0.3; P=2.5E-02) and forced expiration volume in 1 second (FEV1) (r=-0.3; P=2E-02) percentages and directly correlated with composite pulmonary index (CPI) score (r=0.3; P=3.2E-02). A decision-tree statistical algorithm was applied.
CONCLUSIONS CONCLUSIONS
This is the first time that a lower NL-ratio has been demonstrated in sarcoidosis and cHP than in IPF patients. The present preliminary report indicates a relationship between BAL NL-ratio and lung function parameters in patients with IPF: this ratio may help to optimize management of IPF patients and to improve follow-up and outcome.

Identifiants

pubmed: 32407050
pii: S0026-4806.20.06614-8
doi: 10.23736/S0026-4806.20.06614-8
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

526-531

Auteurs

Miriana D'Alessandro (M)

Unit of Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, University Hospital of Siena, Siena, Italy - dalessandro.miriana@gmail.com.

Laura Bergantini (L)

Unit of Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, University Hospital of Siena, Siena, Italy.

Alfonso Carleo (A)

Hannover Medical School, Department of Pulmonology, Hannover, Germany.

Paolo Cameli (P)

Unit of Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, University Hospital of Siena, Siena, Italy.

Anna Perrone (A)

Unit of Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, University Hospital of Siena, Siena, Italy.

Antonella Fossi (A)

Unit of Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, University Hospital of Siena, Siena, Italy.

Piersante Sestini (P)

Unit of Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, University Hospital of Siena, Siena, Italy.

Elena Bargagli (E)

Unit of Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences and Neurosciences, University Hospital of Siena, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH